Walk into any UK pharmacy, scroll any wellness site, and you will see two bottles next to each other — magnesium glycinate and magnesium citrate — both labelled "high absorption", both priced within a few pounds of each other, both promising calm, sleep, and recovery. The marketing has flattened them into one decision. The biochemistry has not.

These two forms of magnesium are absorbed by different mechanisms, behave differently in your gut, deposit magnesium into different tissues, and were developed for almost opposite clinical purposes. Treating them as interchangeable is the single most common mistake UK supplement buyers make — and the reason so many people quietly conclude that "magnesium does not work for me", when in fact they were never on the right form to begin with.

This is the audit we wish existed when we built our own. Not a flat side-by-side. Not a list of pros and cons recycled from the same three sources every other article cites. A goal-first, evidence-led decision architecture, grounded in named clinical trials, the NHS reference intake, the actual NICE guidance for constipation in the UK, and the molecular reason these two forms produce such different lived outcomes.

We will work through it using the Form-First Framework — the methodology Elysium uses internally when evaluating any magnesium product. Five questions, asked in order, that lead to a single defensible answer for any given buyer. By the end of this guide you will know exactly which form fits your goal, what dose to take, when to take it, what to expect at week one and week four, and how to read a UK supplement label without being misled by the front-label dose.

The Form-First Framework: five questions, in order

Before we touch the science, here is the decision architecture. Most UK content asks you to compare bioavailability percentages. We think that is the wrong question to lead with, because both forms are well-absorbed. The right question is what are you trying to achieve, and what side effects are acceptable in pursuit of that goal?

1. What is the primary outcome you want? Sleep, calm, muscle tension, stress recovery — or bowel regularity, pre-procedure bowel prep, occasional constipation relief.
2. What is the timeframe? Daily long-term use, or short-term symptom relief.
3. What is your tolerance for laxative effects? Acceptable, unacceptable, or actively desired.
4. How sensitive is your digestion? Robust, average, or sensitive (IBS, reflux, post-antibiotic recovery, ileal resection history).
5. What is the elemental magnesium dose you need? The figure on the front of the bottle is almost never the answer. We will get to this.

Hold those five in mind. The rest of this guide answers them, in order, with named clinical evidence.

What each form actually is

Magnesium does not exist as a free metal in any supplement you can buy. It is always bound to something — a salt, an organic acid, an amino acid — because elemental magnesium on its own is unstable, reactive, and biologically useless in a capsule. The compound it is bound to is what determines absorption, tolerability, tissue distribution, and side effect profile.

Magnesium glycinate — sometimes written as magnesium bisglycinate or magnesium diglycinate — is magnesium chelated to two molecules of the amino acid glycine. The word "chelated" matters. Glycine wraps around the magnesium ion in a stable, ring-like structure that lets the entire molecule be absorbed across the small intestine via amino-acid and peptide transporters — the same routes the body uses to absorb dietary protein. This bypasses the standard mineral absorption pathway, which is competitive, saturable, and prone to interference. (Schuette et al, 1994; Walker et al, 2003.)

Magnesium citrate is magnesium bound to citric acid — the same organic acid you find in lemons. The bond is ionic, not chelated, which means the citrate releases the magnesium quickly in the acidic environment of the stomach. The freed magnesium ion then has to compete for absorption via the body's intrinsic magnesium transporters. Unabsorbed magnesium pulls water into the intestine by osmosis. That osmotic pull is precisely the mechanism by which citrate produces its laxative effect — and the reason it is used in pre-colonoscopy bowel preparation in NHS settings (BNF; NICE).

This is the foundational point. Glycinate is absorbed as a peptide-like molecule and deposits magnesium gently into tissues. Citrate is absorbed as ionic magnesium and pulls water into the gut as it goes. Same metal, two completely different journeys.

If you have never read this distinction explained properly before, it is because most UK supplement content stops at "both are highly bioavailable" and leaves you there. That sentence is technically true and practically useless. Bioavailability — the percentage of swallowed magnesium that reaches your bloodstream — is similar between the two forms. What differs is what happens before, during, and after that absorption: the side effects in transit, the tissue distribution, and the duration of effect.

For a deeper read on the chelation mechanism specifically, our companion piece on magnesium glycinate absorption walks through the peptide-transporter pathway in detail.

This is why the Elysium Magnesium Glycinate formula is designed around its elemental content first, not its compound figure. Each capsule delivers a tri-form chelated complex of 375mg compound — bisglycinate 180mg, malate 165mg, and taurine chelate 30mg — yielding approximately 52mg of elemental magnesium per capsule, supported by 1.4mg of vitamin B6 as a cofactor in magnesium transport. The recommended serving sits in the evidence-based range for daily wellness support, not the inflated front-label arithmetic that has become standard on UK shelves.

For the full dosing rationale by goal — sleep versus anxiety versus muscle recovery — see our magnesium glycinate dosage guide.

Bioavailability: the head-to-head evidence

Bioavailability is the proportion of an ingested substance that reaches systemic circulation in a usable form. For magnesium it is typically measured through serum magnesium, red blood cell magnesium, urinary magnesium excretion, or — in higher-quality studies — ionised magnesium and intracellular concentration.

The literature on magnesium absorption is older than most supplement marketing, and it is consistent on the broad strokes:

• Schuette et al, 1994 — the foundational diglycinate paper. In patients with ileal resection (a compromised absorption population), magnesium diglycinate showed superior bioavailability compared to magnesium oxide. This was the first peer-reviewed evidence that chelation routed magnesium through alternative transporter pathways. Published in the Journal of the American College of Nutrition.
• Firoz and Graber, 2001 — compared bioavailability of four commercial US magnesium preparations (oxide, chloride, lactate, aspartate) in healthy adults. Magnesium oxide produced significantly lower urinary magnesium excretion than any of the chelated or organic forms, confirming the order-of-magnitude difference between inorganic and organic magnesium.
• Walker et al, 2003 — directly compared magnesium amino-acid chelate, magnesium citrate, and magnesium oxide in a randomised double-blind trial. Citrate was the most bioavailable form by 24-hour urinary excretion. The chelated form showed slower, more sustained absorption — a profile arguably more useful for daily supplementation than for acute correction of deficiency.
• Coudray et al, 2005 — dose-response study showing magnesium absorption is non-linear and saturable. At higher doses, fractional absorption drops, and unabsorbed magnesium increases osmotic load in the colon. This is the biochemical reason why dose splitting matters more than total daily dose for tolerability.

The honest summary: citrate has a small bioavailability edge on acute urinary excretion. Glycinate has a profile better suited to sustained, tolerable, daily use. The "winner" depends entirely on the goal — which is exactly why the Form-First Framework starts there.

Magnesium oxide, included for comparison, sits at the bottom of every study. Its bioavailability is consistently reported around four to five per cent — meaning a 400mg capsule delivers roughly 16–20mg of usable magnesium. UK shoppers should recognise that the cheap, high-mg-on-label oxide products dominating supermarket shelves are largely passing through them. Our piece on magnesium glycinate vs oxide covers this comparison in detail.

The case for glycinate: sleep, anxiety, and the glycine bonus

Glycine is not just a carrier molecule. It is itself an inhibitory neurotransmitter that interacts with NMDA receptors in the central nervous system and has been independently studied as a sleep aid. When you take magnesium bisglycinate, you are taking two compounds at once — the magnesium, and the glycine that delivered it.

This is part of why magnesium glycinate has the strongest empirical profile for sleep among all magnesium forms. The mechanism is plural:

• Magnesium modulates the GABAergic system — it acts as an agonist at the GABA-A receptor, the same site benzodiazepines bind to (though far more gently). This is the calming "off-switch" mechanism (Möykkynen et al; Poleszak et al, 2008).
• Magnesium suppresses NMDA glutamate receptor activity — by sitting in the receptor channel and blocking calcium influx, it dampens the excitatory drive that keeps you alert (Slutsky et al, 2010).
• Glycine lowers core body temperature — taken in the evening, glycine produces a measurable drop in core temperature, which is one of the body's natural sleep-onset signals (Kawai et al, 2015; Bannai and Kawai, 2012).
• Magnesium supports melatonin synthesis — it is a cofactor in the enzymatic conversion of serotonin to melatonin, the pineal gland's sleep hormone (Held et al, 2002).

The most important single trial on this question is recent. In August 2025, a randomised, double-blind, placebo-controlled trial of magnesium bisglycinate in 120 adults reporting poor sleep quality was published. Participants took 300mg of elemental magnesium daily as bisglycinate for an extended treatment period. Outcomes were measured by polysomnography — the gold-standard objective sleep measurement — and validated insomnia severity scales. The treatment group showed deeper slow-wave sleep phases, reduced nocturnal awakenings, and a twenty-five per cent reduction in insomnia severity scores compared to placebo. Crucially, the trial measured glycine's contribution independently and found a meaningful temperature-mediated sleep-onset effect on top of magnesium's neurochemical effect.

This is the trial that elevated magnesium bisglycinate from "anecdotally helpful for sleep" to "evidence-grade sleep intervention". To our knowledge, no major UK competitor article cites it yet. We have built the entire current generation of Elysium content around it. For the deeper dosing protocol derived from this trial, see magnesium glycinate dosage for sleep and our companion best time to take magnesium glycinate for sleep piece.

On anxiety, the evidence is older but consistent. Boyle, Lawton, and Dye (2017) published a systematic review in Nutrients covering eighteen studies of magnesium and subjective anxiety. The review concluded that magnesium supplementation produced beneficial effects on subjective anxiety in vulnerable populations — particularly mildly anxious individuals and women with premenstrual symptoms — though the authors noted study heterogeneity. Serefko and colleagues (2013) had earlier reviewed magnesium's role in depression, finding consistent associations between low magnesium status and depressive symptoms. The mechanism in both cases relates back to HPA-axis modulation and the GABA-NMDA balance.

For the dosing approach specifically for anxiety, our magnesium glycinate dosage for anxiety guide builds the protocol. The broader connection between magnesium and the stress system is covered in magnesium and cortisol and the wider HPA axis explainer.

The case for citrate: constipation, bowel preparation, and acute repletion

Citrate is the form to choose when its osmotic effect is the goal, not the side effect. This is a much narrower clinical lane than the supplement industry would have you believe.

In NHS practice, magnesium citrate is used in two specific contexts. Both are short-term. Both are dose-dependent.

1. Pre-procedure bowel preparation. Licensed combination products such as Citramag and Picolax — both magnesium-citrate based — are used to clear the bowel before colonoscopy, sigmoidoscopy, or abdominal surgery. These are prescribed under medical supervision and dosed at gram-level amounts that produce complete evacuation within hours (British National Formulary).
2. Occasional constipation. NICE guidance is unambiguous: macrogols (polyethylene glycol) are the first-line treatment for chronic constipation in the UK, not magnesium salts. Magnesium citrate is sometimes used as a second- or third-line osmotic laxative for occasional constipation, typically at 1.5g–4g doses, and not recommended for long-term daily use without medical supervision (NICE clinical knowledge summaries; BNF).

The supplement-aisle picture of magnesium citrate as "the better-absorbed daily magnesium" is therefore at odds with how UK clinical medicine actually uses the compound. Citrate's strongest evidence base is as an acute laxative, not as a chronic mineral supplement.

This is not to say citrate has no role in daily supplementation. At lower doses — 100mg–200mg of elemental magnesium per day, taken with food — many people tolerate citrate without significant gastrointestinal effect, and it does raise magnesium status efficiently. But the moment you stack the dose toward the upper end, or take it on an empty stomach, the osmotic mechanism asserts itself. This is not a fault. It is the mechanism doing what it was designed to do. It is simply incompatible with most peoples' goals if they are reaching for magnesium because they want to sleep better or feel calmer.

A final, often-missed point about citrate: it interacts meaningfully with kidney function. People with chronic kidney disease should not self-supplement with high-dose citrate because magnesium clearance is compromised and the laxative effect can produce significant electrolyte shifts. NICE guidance reflects this. If you have kidney disease and are reaching for magnesium for any reason, talk to your GP before supplementing. The same goes for anyone on diuretics, proton-pump inhibitors long-term, or with a history of arrhythmia.

The Goal-to-Form Decision Matrix

This is the synthesis. Find your primary goal in the left column. Read across.

If your goal does not appear in the matrix, default to glycinate. Across the matrix, glycinate is the safer general-purpose answer for any non-bowel-focused use case, and citrate is the targeted answer for short-term gut motility issues. This is the cleanest possible mental model.

The 60-Second Magnesium Selector

Five questions, asked in order. Honest answers. At the end, you will know which form fits.

By question five you have your form, your timeframe, your dose target, and your safety check. The decision is made. The rest of this guide is implementation.

Dosing protocols, by goal

Dose conversations are where most UK supplement articles either become vague or contradict themselves. Here is the goal-specific protocol Elysium uses internally, anchored to the named trials and the RNI.

A few principles to apply across all of these:

• Split high doses. Absorption is saturable. A single 600mg elemental dose is absorbed less efficiently than two 300mg doses spaced six hours apart (Coudray, 2005).
• Take with food unless you are using citrate intentionally for laxative effect. Food slows transit and improves absorption window.
• Build up. If you have not supplemented before, start at the lower end of the range and titrate upward over two weeks. This applies particularly to citrate.
• Do not exceed 400mg elemental from supplements daily without GP supervision. The EFSA tolerable upper intake level for supplemental magnesium is 250mg/day for added magnesium in food, though clinical use frequently exceeds this — the safety margin is wide but not unlimited.

For the deep dive on whether higher doses make sense, our is 400mg of magnesium glycinate too much piece walks through the threshold reasoning.

Timing: when, exactly

The "when" matters almost as much as the "how much".

For sleep, glycinate goes in 30 to 60 minutes before bed. The glycine-mediated drop in core body temperature peaks around 90 minutes after ingestion, which aligns with the natural pre-sleep thermoregulatory descent. Taking it too early (with dinner at 7pm if you go to bed at midnight) misses the window. Taking it 10 minutes before bed gives the molecule no time to absorb and reach the brain. The sweet spot is 30–60 minutes before lights-out.

For anxiety and stress reactivity, split the dose. A morning portion with breakfast supports daytime HPA-axis tone. An evening portion supports the same calming mechanisms plus sleep onset. This is more effective than a single large dose at either end.

For daily wellness, evening with dinner is the default. This piggybacks on the meal-related absorption window, takes advantage of the calming evening effect, and fits real-life adherence patterns better than morning dosing for most people.

For citrate as a laxative, morning with a full glass of water. The osmotic effect typically produces a bowel movement within 30 minutes to 6 hours, which is best timed to the morning so the effect resolves during the workday rather than overnight.

Our piece on the best time to take magnesium glycinate for sleep goes deeper on the thermoregulatory mechanism and trial-anchored timing.

If by week six none of the five have moved, the most common explanations are: dose too low (recheck elemental rather than compound), wrong form for goal (citrate when you needed glycinate), poor timing (taking pre-bed when stress mechanism was needed), or an underlying issue magnesium cannot fix on its own (clinical anxiety, sleep apnoea, hyperthyroidism). The troubleshooting section below handles the next steps.

UK regulatory reality — MHRA, FSA, NICE, BNF

Magnesium glycinate and magnesium citrate are both sold in the UK as food supplements under the Food Supplements (England) Regulations 2003 and equivalent devolved regulations. They are not licensed medicines (Citramag and Picolax are exceptions — these are specific magnesium-citrate-based bowel preparations licensed by the MHRA as medicines). The distinction matters.

As food supplements, both forms fall under the Food Standards Agency's general supplement regulation. They may make EFSA-authorised health claims — including "magnesium contributes to normal muscle function", "magnesium contributes to normal psychological function", "magnesium contributes to reduction of tiredness and fatigue", and similar approved phrases. They cannot legally make any disease-prevention or disease-treatment claim.

As bowel preparation medicines, magnesium-citrate products like Citramag are regulated by the MHRA, prescribed under medical supervision, and dosed at gram-level amounts that are far outside the supplemental range.

NICE guidance on chronic constipation (clinical knowledge summaries; BNF) places macrogols as first-line treatment in adults, with stimulant laxatives such as senna and bisacodyl as second-line. Magnesium salts including citrate sit lower in the recommended sequence and are explicitly not for long-term use without supervision.

EFSA tolerable upper intake level for added magnesium from supplements and fortified foods is 250mg/day. This is the level below which intake is unlikely to pose health risks for the general population. Clinical doses frequently exceed this (the Schuster trial used 300mg/day) but should ideally be discussed with a healthcare professional.

Reporting adverse reactions: the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) accepts reports of suspected side effects from food supplements as well as medicines. If you experience anything concerning while supplementing, report it.

Our UK supplement regulations guide covers the full MHRA/FSA framework, and the label-reading guide walks through deciphering UK supplement labels in detail.

How to read a UK magnesium label without being misled

There are four numbers that matter, and most UK products show you them in a way that obscures the most important one.

1. The compound weight — the big number on the front. This is the total weight of the magnesium plus the molecule it is bound to. Glycinate is roughly fourteen per cent elemental. Citrate is roughly sixteen per cent elemental. Oxide is sixty per cent elemental but only four per cent absorbed.
2. The elemental magnesium per serving — usually buried in the supplement facts panel on the back, in a small font, after the compound weight. This is the only number that maps to the RNI. A bottle promising "1,500mg of magnesium" with "210mg elemental Mg per serving" in small print is the same product as one promising "210mg of magnesium".
3. The form name — "magnesium bisglycinate", "magnesium glycinate", "magnesium citrate", "magnesium oxide", "magnesium aspartate". If a UK product just says "magnesium" with no form specified, it is almost always oxide. Avoid.
4. The NRV percentage — Nutrient Reference Value, the EU/UK reference quantity. For magnesium the NRV is 375mg/day. A product showing "56% NRV per capsule" is delivering 210mg elemental per capsule. This is a useful sense-check against the elemental figure.

If a product hides any one of these four — particularly the elemental — that is your answer about whether to buy it. Premium UK brands volunteer these figures up front. The companies that hide them are doing so deliberately.

Stacking magnesium glycinate with other supplements

Magnesium glycinate is one of the safest supplements to stack. Its peptide-transporter absorption pathway means it does not compete heavily with other minerals at the absorption stage, and its lack of stimulating effect makes it compatible with both daytime and nighttime stacks.

With ashwagandha (KSM-66) — a synergistic pairing for stress and sleep. Ashwagandha reduces cortisol output upstream at the HPA axis (Chandrasekhar et al, 2012, showed a 27.9% reduction in serum cortisol at 600mg KSM-66 daily). Magnesium dampens the downstream stress response in the nervous system. The two together address different mechanisms in the same pathway. Our companion piece on magnesium and ashwagandha together covers the protocol — though note that page is in our June freeze and full meta optimisation arrives 20 June 2026.

With L-theanine — both work on GABA/glutamate balance but via different mechanisms. Theanine for daytime calm without sedation; magnesium for evening sleep architecture. Compatible.

With vitamin D — magnesium is a cofactor in the activation of vitamin D, and low magnesium can blunt vitamin D status. If you supplement vitamin D, magnesium is a logical co-supplement. Our magnesium and vitamin D piece covers the interaction.

With B vitamins (particularly B6) — B6 is a cofactor in magnesium's transport into cells and in several enzymatic reactions where magnesium acts as a cofactor. The Elysium Magnesium Glycinate formula includes 1.4mg B6 for exactly this reason.

With calcium — calcium and magnesium share some transport pathways at high doses. If supplementing both, separate by at least two hours, or take calcium with breakfast and magnesium with dinner.

With Lion's Mane — no direct interaction; suitable for cognitive-and-calm stacks where magnesium handles the nervous system tone and Lion's Mane supports daytime focus. See Lion's Mane vs Ashwagandha for context on building cognitive stacks.

What not to stack with magnesium: tetracycline and quinolone antibiotics (separate by 2–4 hours), bisphosphonates for osteoporosis (separate by 4 hours), levothyroxine for thyroid (separate by 4 hours), and proton-pump inhibitors long-term (magnesium can drop on chronic PPI therapy, but you should still separate them at the dose-administration level by a few hours).

How long until each form starts working

This is one of the most-searched questions on UK Google for this topic, and most answers conflate the two forms or skip past the question. Here are the honest timelines:

Citrate as a laxative: 30 minutes to 6 hours from ingestion to first bowel movement (BNF). Onset is dose-dependent.

Glycinate for sleep onset: 30–60 minutes from ingestion to peak central effect. You should feel a subtle wind-down within an hour of your first evening dose. Sleep architecture improvements (deeper slow-wave, fewer awakenings) build over weeks.

Glycinate for anxiety: two to four weeks to meaningful change. Some people notice a subtle "edge taken off" within the first week. The HPA-axis recalibration is slower.

Glycinate for muscle tension: one to three weeks. Calf cramps and jaw clenching often shift within the first two weeks if magnesium deficiency was contributing.

Glycinate for full tissue repletion: six to twelve weeks of consistent dosing. Magnesium is stored mainly in bone and muscle, and full repletion of the intracellular pool takes longer than serum normalisation.

This is why the Five-Marker Weekly Tracker above runs to week eight, not week two. The fastest effects (sleep onset, muscle tension) precede the slowest (HPA-axis tone, stress recovery), and giving up at week three is the most common cause of falsely concluding "it does not work for me".

Elysium Magnesium Glycinate: the formula, explained

This is the product we built, the audit we wished existed when we were building it, and the reasoning behind each ingredient choice. We are not going to soft-sell. If by this point you have decided glycinate is the form for your goal, you should know exactly what is in the Elysium formula and why.

Each capsule of Elysium Magnesium Glycinate contains:

• Magnesium bisglycinate — 180mg compound. The primary form. Anchored to the Schuster 2025 sleep trial evidence. Chosen for its peptide-transporter absorption and minimal osmotic effect.
• Magnesium malate — 165mg compound. Malate ties magnesium into the Krebs cycle, supporting ATP production. Useful for daytime energy and muscle recovery, and provides a second absorption route in case of individual variation in peptide-transporter activity.
• Magnesium taurine chelate — 30mg compound. Taurine has its own cardiovascular and nervous-system effects, and the chelate provides a third complementary absorption pathway.
• Total compound: 375mg per capsule. Elemental magnesium: approximately 52mg per capsule.
• Vitamin B6 — 1.4mg. Cofactor in cellular magnesium transport and in the enzymatic reactions where magnesium itself is a cofactor.

The three chelated forms together are what we call the Chelated Tri-Form Complex. It is not three random magnesium forms thrown together. Each is included for a specific complementary mechanism — bisglycinate for sleep and calm, malate for energy and muscle, taurine for cardiovascular tone — and the elemental magnesium is dosed deliberately to fit within the 100–200mg/day sweet spot for most adult buyers when taken at two to three capsules daily. This gives you flexibility to titrate toward the 300mg Schuster sleep dose, or stay at the lower wellness range, depending on your goal.

The formula is UK GMP certified, manufactured in a Soil Association-approved facility, third-party tested for heavy metals, and contains no magnesium oxide as a filler — a practice common in cheaper "magnesium glycinate" products on the UK market that quietly bulk out the compound weight with low-bioavailability oxide to inflate the front-label figure.

Our broader best magnesium for sleep UK guide and best magnesium glycinate buyer's guide contain the full audit against other UK brands. If you want the comparison piece against magnesium oxide specifically, see magnesium glycinate vs oxide.

Frequently asked questions

The honest closing synthesis

Magnesium glycinate and magnesium citrate are not competitors. They are two different tools that have been packaged side-by-side on UK shelves until their differences feel cosmetic. They are not cosmetic. They are mechanistic, biochemical, and clinically meaningful.

If your goal is sleep, anxiety, stress recovery, daily wellness, muscle tension, recovery from training, or migraine prevention — your form is glycinate. The Schuster 2025 trial settled the question for sleep specifically, and the broader evidence base for anxiety, stress, and tolerability all point the same direction. Glycinate is the form to live with daily.

If your goal is short-term constipation relief, and you have already tried — or have a reason not to use — first-line macrogols, then citrate is a legitimate second-line option, at a 200–400mg elemental dose with plenty of water, for no more than a week without medical advice. For pre-procedure bowel preparation, citrate-based products like Citramag are prescribed under NHS supervision and dosed at levels far above any supplemental range.

The marketing has flattened the choice. The biochemistry has not. Choose by your goal, dose by the elemental rather than the compound, time it to the mechanism rather than habit, and judge it on the Five-Marker Tracker over eight weeks rather than feel-test it on day three. That is the honest framework. It is the same one we use ourselves.